NCT05766631
Treating Polysubstance Use Using a Novel Digital Technology
Active, Not Recruiting
PHASE3Ages 18+InterventionalTreatmentFriends Research Institute, Inc.Investigator-initiated
~240 participants
Updated 2026-05-19 on ClinicalTrials.gov
What's tested:DynamiCare HealthMethadone Treatment-As-Usual
At a glance
Recruiting sites
0 of 5 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Retention in Methadone Treatment through 48 Weeks
Measured over 48 weeks
Conditions
Where it's being run
5 sites across 1 statesMaryland5
Study leadership
- Karen Alexander, Ph.D. · PRINCIPAL_INVESTIGATOR · Friends Research Institute, Inc.
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Retention in Methadone Treatment through 48 Weeks48 weeks
The primary outcome of the proposed study is retention in methadone treatment, which will be determined via clinic attendance records, and will be defined as 7 days of continuous absence from scheduled clinic medication visits at any point during the 48-week intervention period.